Pharmacology

Antiplatelet

Appendage trans-catheter closure is equivalent to anticoagulation in fibrillated patients.

Original title: Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of...

solaci - 1 March, 2013

Learn More

Interventional Cardiologists

Endovascular therapy after t-PA: no additional benefit for patients with acute stroke

Original title: Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke. Interventional Management of Stroke (IMS) III. Reference: Joseph...

solaci - 14 February, 2013

Learn More

Acute coronary syndromes

Serum fibrinogen is a better predictor of periprocedural events than platelet reactivity.

Original title: Elevated Plasma Fibrinogen Rather Than Residual Platelet Reactivity After Clopidogrel Pre-Treatment Is Associated With an Increased...

solaci - 9 January, 2013

Learn More

Acute coronary syndromes

Ticagrelor, even better than we thought

Original title: Reduction in First and Recurrent Cardiovascular Events with Ticagrelor Compared with Clopidogrel in the PLATO Study. Reference: Payal...

solaci - 8 January, 2013

Learn More

Antithrombotic Anticoagulants

Does the systematic use of clopidogrel reduce events prior to angioplasty?

Original title: Association of Clopidogrel Pretreatment with mortality, Cardiovascular events, and Major Bleeding among patients undergoing percutaneous coronary...

solaci - 2 January, 2013

Learn More

Infrapatellar

Cilostazol reduces restenosis in infrapopliteal angioplasty

Original title: Impact of Cilostazol on Angiographic Restenosis after Balloon Angioplasty for Infrapopliteal Artery Disease in Patients with...

solaci - 30 November, 2012

Learn More

Chronic Ischemic cardiopathy

High-dose atorvastatin for prevention of contrast nephropathy

Original title: Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury. Reference: Quintavalle et al. CIRCULATIONAHA.112.10331,...

solaci - 27 November, 2012

Learn More

Acute coronary syndromes

To discontinue clopidogrel after a year of infarction can be risky

Reference: Charlot et al. European Heart Journal 2012 (in press).International guideline recommendations approve giving dual antiplatelet therapy...

solaci - 1 October, 2012

Learn More

Appendage trans-catheter closure is equivalent to anticoagulation in fibrillated patients.

Endovascular therapy after t-PA: no additional benefit for patients with acute stroke

Serum fibrinogen is a better predictor of periprocedural events than platelet reactivity.

Ticagrelor, even better than we thought

Does the systematic use of clopidogrel reduce events prior to angioplasty?

Cilostazol reduces restenosis in infrapopliteal angioplasty

High-dose atorvastatin for prevention of contrast nephropathy

To discontinue clopidogrel after a year of infarction can be risky

Last News

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Institutional News

SOLACI Wishes You Happy Holidays

Condolences on the passing of Cristiam Arancibia

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Access